// App-Quantinova.ai

P310 : BH3 PROFILING IDENTIFIES SELECTIVE BCL-2 DEPENDENCE OF ADULT EARLY T-CCELL PROGENITOR AND TYPICAL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Researchers

Presenter

  • Karanpreet Bhatia

Principal Investigators

  • Jacqueline Garcia

  • Nitin Jain

  • Wei Ying Jen

  • Anthony Letai

  • Marina Konopleva

  • Shruti Bhatt

Medical Centers

  • Department of Haematology-Oncology, National University Hospital, Singapore

  • Department of Pharmacy,Natio

  • Department of Pathology, National University of Singapore, Singapore, Singapore

  • Department of Leukemia,University of Texas MD Anderson Cancer Center,Houston,Vereinigte Staaten

  • Department of Pharmacy,National University of Singapore,Singapore,新加坡

  • Department of Leukemia,University of Texas MD Anderson Cancer Center,Houston,Vereinigte Staaten

  • Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore

  • Department of Pathology, National University of Singapore, Singapore, Singapore

  • Department of Pathology, National University of Singapore, Singapore, Singapore

  • Department of Leukemia,University of Texas MD Anderson Cancer Center,Houston,Vereinigte Staaten

  • Department of Pathology, National University of Singapore, Singapore, Singapore

  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  • Medical Oncology,Dana-Farber Cancer Institute,Boston,Vereinigte Staaten

  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

  • Medical Oncology,Dana-Farber Cancer Institute,Boston,Vereinigte Staaten

  • Department of Medical Oncology,Dana-Farber Cancer Institute,MA,Estados Unidos

  • Department of Pathology, National University of Singapore, Singapore, Singapore

  • Department of Pathology, National University of Singapore, Singapore, Singapore

  • Department of Medical Oncology,Dana-Farber Cancer Institute,MA,Estados Unidos

  • Department of...

  • Department of Medical Oncology,Dana-Farber Cancer Institute,MA,Estados Unidos

  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Department of Haematology-Oncology,National Univers

  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Locations

  • Singapore

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved